Interview with Chris Molloy (IDBS) on software solutions for pharma R&D

Written by Thomas Payne, Future Science Group

serum in petri dishes on light pink background cosmetic research concept

Chris Molloy (IDBS) spoke to Bioanalysis Zone in September 2011. Could you tell Bioanalysis Zone a little about your career to date and how you ended up in your current role? My career started in cell biology/biochemistry with GlaxoSmithKline in 1990 at the very beginning of the drive to industrialize R&D. Through 14 years with the company, I moved across many therapeutic and scientific disciplines from cancer and respiratory disease to Alzheimer’s and a range of enzyme-based therapeutic targets, working internally and in collaboration with biotech. As the company expanded, I became increasingly responsible for preclinical business improvement projects, coordinating IT...

To view this content, please register now for access

It's completely free